1. Home
  2. SRTA vs SCTX Comparison

SRTA vs SCTX Comparison

Compare SRTA & SCTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

SRTA

Strata Critical Medical Inc.

SELL

Current Price

$4.48

Market Cap

530.4M

Sector

N/A

ML Signal

SELL

Logo Scribe Therapeutics Inc. Common Stock

SCTX

Scribe Therapeutics Inc. Common Stock

N/A

Current Price

$19.03

Market Cap

536.5M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
SRTA
SCTX
Founded
2014
2017
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
530.4M
536.5M
IPO Year
2019
2026

Fundamental Metrics

Financial Performance
Metric
SRTA
SCTX
Price
$4.48
$19.03
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
4
4
Target Price
$9.56
★ $57.00
AVG Volume (30 Days)
★ 758.6K
500.7K
Earning Date
11-09-2026
11-29-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 242.86
N/A
EPS
★ N/A
N/A
Revenue
★ $197,141,000.00
N/A
Revenue This Year
$47.51
N/A
Revenue Next Year
$12.14
N/A
P/E Ratio
★ N/A
N/A
Revenue Growth
N/A
★ N/A
52 Week Low
$3.95
$13.50
52 Week High
$6.50
$39.60

Technical Indicators

Market Signals
Indicator
SRTA
SCTX
Relative Strength Index (RSI) 29.64 40.84
Support Level $4.21 $13.50
Resistance Level $4.69 $26.50
Average True Range (ATR) 0.18 2.79
MACD -0.05 -0.01
Stochastic Oscillator 11.39 41.57

Price Performance

Historical Comparison
SRTA
SCTX

About SRTA Strata Critical Medical Inc.

Strata Critical Medical Inc is a time-critical logistics and medical services provider to the U.S. healthcare industry. The group operates one of the nation's air transport and surgical services networks for transplant hospitals and organ procurement organizations, offering an integrated 'One Call' solution for donor organ recovery. It includes two segments: Logistics segments which hold, Air Logistics, Ground Logistics and Organ Placement. The second segment is Clinical Segment which includes: Organ Recovery, Normothermic Regional Perfusion (NRP), and Preservation, and Other Clinical Segment which has Cardiac Care, and Other.

About SCTX Scribe Therapeutics Inc. Common Stock

Scribe Therapeutics Inc is a clinical-stage biotechnology company engaged in the development of in vivo CRISPR-based genetic medicines. Its research and development activities focus on cardiovascular and metabolic diseases, including atherosclerotic cardiovascular disease (ASCVD). The company's product pipeline includes STX-1150, a CRISPR-based product candidate that utilizes its ELXR epigenetic silencing technology.

Share on Social Networks: